Literature DB >> 17804232

Evaluation of protein farnesyltransferase substrate specificity using synthetic peptide libraries.

Amanda J Krzysiak1, Sarah A Scott, Katherine A Hicks, Carol A Fierke, Richard A Gibbs.   

Abstract

Farnesylation, catalyzed by protein farnesyltransferase (FTase), is an important post-translational modification guiding cellular localization. Recently predictive models for identifying FTase substrates have been reported. Here we evaluate these models through screening of dansylated-GCaaS peptides, which also provides new insights into the protein substrate selectivity of FTase.

Mesh:

Substances:

Year:  2007        PMID: 17804232      PMCID: PMC2077820          DOI: 10.1016/j.bmcl.2007.08.024

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

Review 1.  Galectins in cell growth and apoptosis.

Authors:  R Y Yang; F T Liu
Journal:  Cell Mol Life Sci       Date:  2003-02       Impact factor: 9.261

Review 2.  Opinion: Searching for the elusive targets of farnesyltransferase inhibitors.

Authors:  Saïd M Sebti; Channing J Der
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

3.  A tagging-via-substrate technology for detection and proteomics of farnesylated proteins.

Authors:  Yoonjung Kho; Sung Chan Kim; Chen Jiang; Deb Barma; Sung Won Kwon; Jinke Cheng; Janis Jaunbergs; Carolyn Weinbaum; Fuyuhiko Tamanoi; John Falck; Yingming Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-12       Impact factor: 11.205

4.  Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.

Authors:  T Scott Reid; Kimberly L Terry; Patrick J Casey; Lorena S Beese
Journal:  J Mol Biol       Date:  2004-10-15       Impact factor: 5.469

Review 5.  Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets.

Authors:  Panagiotis A Konstantinopoulos; Michalis V Karamouzis; Athanasios G Papavassiliou
Journal:  Nat Rev Drug Discov       Date:  2007-07       Impact factor: 84.694

6.  Investigation of S-farnesyl transferase substrate specificity with combinatorial tetrapeptide libraries.

Authors:  J A Boutin; W Marande; L Petit; A Loynel; C Desmet; E Canet; J L Fauchère
Journal:  Cell Signal       Date:  1999-01       Impact factor: 4.315

Review 7.  Lipid posttranslational modifications. Farnesyl transferase inhibitors.

Authors:  Andrea D Basso; Paul Kirschmeier; W Robert Bishop
Journal:  J Lipid Res       Date:  2005-11-08       Impact factor: 5.922

8.  Protein prenylation in an insect cell-free protein synthesis system and identification of products by mass spectrometry.

Authors:  Takashi Suzuki; Masaaki Ito; Toru Ezure; Masamitsu Shikata; Eiji Ando; Toshihiko Utsumi; Susumu Tsunasawa; Osamu Nishimura
Journal:  Proteomics       Date:  2007-06       Impact factor: 3.984

9.  Combinatorial modulation of protein prenylation.

Authors:  Amanda J Krzysiak; Diwan S Rawat; Sarah A Scott; June E Pais; Misty Handley; Marietta L Harrison; Carol A Fierke; Richard A Gibbs
Journal:  ACS Chem Biol       Date:  2007-05-25       Impact factor: 5.100

10.  Refinement and prediction of protein prenylation motifs.

Authors:  Sebastian Maurer-Stroh; Frank Eisenhaber
Journal:  Genome Biol       Date:  2005-05-27       Impact factor: 13.583

View more
  11 in total

1.  Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Authors:  Thangaiah Subramanian; Suxia Liu; Jerry M Troutman; Douglas A Andres; H Peter Spielmann
Journal:  Chembiochem       Date:  2008-11-24       Impact factor: 3.164

2.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

Authors:  James L Hougland; Katherine A Hicks; Heather L Hartman; Rebekah A Kelly; Terry J Watt; Carol A Fierke
Journal:  J Mol Biol       Date:  2009-10-28       Impact factor: 5.469

3.  Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.

Authors:  James L Hougland; Soumyashree A Gangopadhyay; Carol A Fierke
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

4.  Synthesis of Non-natural, Frame-Shifted Isoprenoid Diphosphate Analogues.

Authors:  Kayla J Temple; Elia N Wright; Carol A Fierke; Richard A Gibbs
Journal:  Org Lett       Date:  2016-11-14       Impact factor: 6.005

5.  Solid-phase synthesis of C-terminal peptide libraries for studying the specificity of enzymatic protein prenylation.

Authors:  Yen-Chih Wang; Mark D Distefano
Journal:  Chem Commun (Camb)       Date:  2012-07-11       Impact factor: 6.222

6.  Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates.

Authors:  Amanda J Krzysiak; Animesh V Aditya; James L Hougland; Carol A Fierke; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2009-11-12       Impact factor: 2.823

7.  Peptide-conjugated pterins as inhibitors of ricin toxin A.

Authors:  Ryota Saito; Jeff M Pruet; Lawrence A Manzano; Karl Jasheway; Arthur F Monzingo; Paul A Wiget; Ishan Kamat; Eric V Anslyn; Jon D Robertus
Journal:  J Med Chem       Date:  2012-12-19       Impact factor: 7.446

Review 8.  Recent progress in enzymatic protein labelling techniques and their applications.

Authors:  Yi Zhang; Keun-Young Park; Kiall F Suazo; Mark D Distefano
Journal:  Chem Soc Rev       Date:  2018-09-27       Impact factor: 54.564

Review 9.  Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease.

Authors:  Angela Jeong; Kiall Francis Suazo; W Gibson Wood; Mark D Distefano; Ling Li
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-06       Impact factor: 8.250

10.  Context-dependent substrate recognition by protein farnesyltransferase.

Authors:  James L Hougland; Corissa L Lamphear; Sarah A Scott; Richard A Gibbs; Carol A Fierke
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.